Munir Ghesani
Director & Chief Medical Officer United Theranostics
Dr. Munir Ghesani, MD, FACNM, FACR, FSNMMI, is a distinguished leader in nuclear medicine, with a career spanning over 25 years in academic practice. He currently serves as the Chief Medical Officer at United Theranostics and as the System Chief of Nuclear Medicine at the Mount Sinai Health System in New York. Additionally, he holds the position of Associate Clinical Professor of Radiology at the Icahn School of Medicine at Mount Sinai.
Seminars
Thursday 23rd July 2026
Optimizing Radiopharmaceutical Dosing Within FDA Guidance: Strategies to Maximize Efficacy & Minimize Toxicity
1:30 pm
- Interpreting current FDA guidance on dose selection, escalation, and optimization for radioligand therapies
- Integrating pharmacokinetics, biodistribution, and safety data to refine patient-specific dosing strategies
- Applying regulatory best practices to design trials that balance therapeutic efficacy with minimization of off-target toxicity
Tuesday 21st July 2026
Designing a Radiopharmaceutical Clinical Trial: Key Considerations from the Start
2:00 pm
- Outlining the network of clinical experts who are involved from nuclear medical physicians to medical oncologists
- Key differences in a radiopharma trial
- Radiation safety considerations
- If clinical trials require a clinical sub study/assessment?
- Importance of onsite imaging
